On Friday, Shares of NRG Energy Inc (NYSE:NRG), gained 0.59% to $12.00.
NRG Energy, Inc. (NRG) and NRG Yield (NYSE: NYLD, NYLD.A), declared the following executive appointments in finance effective January 4, 2016: Gaetan Frotte, Senior Vice President, Finance and Strategy of NRG Yield, will become Senior Vice President and Treasurer of NRG; Chad Plotkin, Vice President, Investor Relations, will become Senior Vice President, Finance and Strategy for NRG Yield; and Kevin Cole will join NRG as Senior Vice President of Investor Relations.
“At this important time in NRG’s history, we are happy to be leveraging existing talent and bringing in new expertise to further strengthen our corporate finance resources, provide ongoing support and leadership for NRG Yield while ongoing to improve our ability to clearly and effectively communicate with stakeholders,” said Kirk Andrews, NRG and NRG Yield Chief Financial Officer.
Both Gaetan Frotte and Chad Plotkin bring deep industry experience and financial expertise to their new roles in the NRG and NRG Yield organizations. Preceding to his role as Head Finance and Strategy for NRG Yield, Gaetan Frotte served as Assistant Treasurer of NRG. Preceding to leading Investor Relations at NRG, Chad Plotkin led the Finance organization for NRG Home Solar and formerly served in the Strategy, Mergers and Acquisitions organization for NRG.
NRG Energy, Inc., together with its auxiliaries, operates as a power company. The company provides electricity; system power, distributed generation, solar and wind products, backup generation, storage and distributed solar, demand response, energy efficiency, and on-site energy solutions; carbon administration and specialty services; and various energy services, such as operations, maintenance, technical, development, and asset administration services.
Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), inclined 1.11% to $61.72, during its last trading session.
Teva Pharmaceutical Industries Ltd. and University College London, declared the start of a unique study, combining state-of-the-art brain imaging with key biomarkers, aimed at building a better understanding of the role of inflammation in neurodegenerative disease and potentially a new approach in its early diagnosis and treatment.
The Pilot Longitudinal Study in Alzheimer’s Disease of Central Markers of Microglial Activation (PADMMA) study is a two-year study in 20 patients that will assess, using PET imaging, the prevalence and pattern of activation of a specific type of cell, called microglia, in the central nervous system (CNS) in people with certain symptoms of neurodegenerative disease. It is key demonstration of Teva’s commitment towards dementia research made following the UK Government’s Dementia Summit, spearheaded by UK Prime Minister David Cameron.
The role of inflammation is key in the field of neurodegeneration. It is implicated in the neuronal dysfunction that is the result of some of the most devastating neurodegenerative diseases. Microglia play a central role in neuro-inflammation, and defining reliable biomarkers of microglial activation, and their changes over time, will provide us with crucial information for developing treatment trials with neuro-inflammation as a novel therapeutic target.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines.
Finally, Shares of Coeur Mining Inc (NYSE:CDE), ended its last trade with -3.50% loss, and closed at $2.48.
Coeur Mining, Inc.’s Senior Vice President and Chief Financial Officer, Peter C. Mitchell, will present at the Silver Summit and Resource Expo on November 23, 2015 at about 2:45 p.m. local time.
Coeur Mining, Inc., through its auxiliaries, engages in the ownership, operation, exploration, and development of silver and gold mining properties primarily in the United States, Mexico, Bolivia, Argentina, Australia, Ecuador, Chile, and New Zealand. Its principal properties comprise the Palmarejo silver and gold mine in Mexico; San Bartolomé silver mine in Bolivia; Kensington gold mine located in Alaska; the Rochester silver and gold mine in Nevada; and the Endeavor mine, an underground zinc, lead, and silver mine in Australia.